Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Note: While Ozempic and Wegovy are FDA-approved for diabetes and weight loss respectively, many patients access the same active ingredient through compounded semaglutide prepared by FDA-registered, inspected compounding pharmacies
Semaglutide is a GLP-1 receptor agonist, which works by mimicking a natural hormone in the body that regulates appetite and blood sugar levels
Diabetes prescribing involves HbA1c monitoring and, importantly, review of your other glucose-lowering medicines
However, the manufacturer guidelines provide a specific window for flexibility
Composicin Principio activo: Semaglutida Concentracin: 2 mg/1.5 ml Presentacin: Pluma precargada de 1.5 ml Forma farmacutica: Solucin inyectable subcutnea Indicaciones teraputicas Diabetes tipo 2 en adultos Control de glucosa en combinacin con dieta y ejercicio Reduccin del riesgo cardiovascular en pacientes con enfermedad cardaca Apoyo en el control del peso corporal Modo de uso Aplicar por va subcutnea (abdomen, muslo o brazo) una vez por semana, preferiblemente el mismo da
